FFC0.F OAKTR.SPEC.LEND.NEW
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- 11.50%
- Fundamental score
- -
Is FFC0.F undervalued?
Graham numberThe Graham number of OAKTR.SPEC.LEND.NEW cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
OAKTR.SPEC.LEND.NEW fundamental analysis
No fundamental analysis for OAKTR.SPEC.LEND.NEW yet.
OAKTR.SPEC.LEND.NEW stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About OAKTR.SPEC.LEND.NEW
Oaktree Specialty Lending Corporation is a business development company. The fund specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity, and management buyouts in small and mid-sized companies. It seeks to invest in education services, business services, retail and consumer, healthcare, manufactur…
Full company profileFinancial statements of OAKTR.SPEC.LEND.NEW are not available yet.
OAKTR.SPEC.LEND.NEW dividends
OAKTR.SPEC.LEND.NEW has not paid dividends in the last 3 fiscal years.
Last stock split: 0.333333:1 on Jan 23, 2023.
Who owns OAKTR.SPEC.LEND.NEW
- Insiders 0.30%
- Institutions 50.74%
- Public & others 48.96%
OAKTR.SPEC.LEND.NEW company profile
- Company name
- OAKTR.SPEC.LEND.NEW
- Ticker
- FFC0.F
- Exchange
- Frankfurt Exchange
- Sector
- Financial Services
- Industry
- Oil, Gas & Consumable Fuels
- Fiscal year end
- September
- Address
- 333 South Grand Avenue, Los Angeles, CA, United States, 90071
- Phone
- 213 830 6300
- Website
- oaktreespecialtylending.com
About OAKTR.SPEC.LEND.NEW
Oaktree Specialty Lending Corporation is a business development company. The fund specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity, and management buyouts in small and mid-sized companies. It seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering. The firm also seeks investment in media, advertising sectors, software, IT services, pharmaceuticals, biotechnology, real estate management and development, chemicals, machinery, and internet and direct marketing retail sectors. It invests between $5 million to $75 million principally in the form of one-stop, first lien, and second lien debt investments, which may include an equity co-investment component in companies. The firm invest in companies having enterprise value between $20 million and $150 million and EBITDA between $3 million and $50 million. The fund has a hold size of up to $75 million and may underwrite transactions up to $100 million. It primarily invests in North America. The fund seeks to be a lead investor in its portfolio companies.
OAKTR.SPEC.LEND.NEW management
10- Mr. Armen Panossian J.D.CEO & Co-Chief Investment Officer · born 1976
- Mr. Mathew M. PendoPresident · born 1964
- Dr. Aman Kumar M.D.Managing Director & Co-Portfolio Manager of Life Sciences Direct Lending · born 1980
- Mr. Christopher McKownCFO & Treasurer · born 1982
- Mr. Brett McKeoneChief Operating Officer
- Mr. Raghav KhannaCo-Chief Investment Officer · born 1984
- Mr. Dane KlevenSenior VP & Head of Investor Relations
- Ms. Mary Gallegly J.D.MD,General Counsel & Secretary
- Ms. Ashley PakChief Compliance Officer · born 1978
- Mr. Sandeep Kumar KhoranaManaging Director of Origination · born 1973